Previving: How Unaffected Women with a <i>BRCA1/2</i> Mutation Navigate Previvor Identity

Hannah Getachew-Smith, Amy A. Ross, Courtney L. Scherr, Marleah Dean, Meredith L. Clements

Health Communication · 2019 · 19 citations · 51 references

Concepts

Abstract

Receiving a positive result for a BRCA1/2 (BRCA) mutation – indicating a high lifetime risk to develop hereditary breast and ovarian cancer – can significantly alter a woman’s identity. BRCA-positive women who have not been diagnosed with cancer may be labeled “previvors,” which distinguishes those at-risk for developing cancer, but have not had cancer. Using semi-structured interviews (N = 25), this study explored how unaffected BRCA-positive women navigate the previvor identity. Women in this sample differed on their definitions of previvor, views of acceptance, rejection, or ambivalence toward the label, and identification as a previvor. Understanding how women interpret and embrace the previvor identity may help inform communication for those with BRCA genetic mutations, but whom have not been diagnosed with cancer.

References

51